Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structural insights into multiplexed pharmacological actions of tirzepatide and peptide 20 at the GIP, GLP-1 or glucagon receptors
Fenghui Zhao, Qingtong Zhou, Zhaotong Cong, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 94

Showing 1-25 of 94 citing articles:

Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review
Vivek P. Chavda, Jinal Ajabiya, Divya Teli, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4315-4315
Open Access | Times Cited: 122
GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach
Jingyue Wang, Quanwei Wang, Xinyu Yang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 121
BI 456906: Discovery and preclinical pharmacology of a novel GCGR/GLP-1R dual agonist with robust anti-obesity efficacy
Tina Zimmermann, Leo Thomas, Tamara Baader-Pagler, et al.
Molecular Metabolism (2022) Vol. 66, pp. 101633-101633
Open Access | Times Cited: 81
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zhikai Zheng, Zong Yao, Yiyang Ma, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 73
Recent advances in chemical protein synthesis: method developments and biological applications
Suwei Dong, Ji‐Shen Zheng, Yiming Li, et al.
Science China Chemistry (2024) Vol. 67, Iss. 4, pp. 1060-1096
Closed Access | Times Cited: 59
Glucagon-Like Peptide-1: New Regulator in Lipid Metabolism
Tong Bu, Ziyan Sun, Yi Pan, et al.
Diabetes & Metabolism Journal (2024) Vol. 48, Iss. 3, pp. 354-372
Open Access | Times Cited: 22
Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists
Qiyuan Keith Liu
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 16
Efficacy and Safety of Liraglutide and Semaglutide on Weight Loss in People with Obesity or Overweight: A Systematic Review
Zeyu Xie, Sensen Yang, Weishang Deng, et al.
Clinical Epidemiology (2022) Vol. Volume 14, pp. 1463-1476
Open Access | Times Cited: 55
Tirzepatide: A Systematic Update
Imma Forzano, Fahimeh Varzideh, Roberta Avvisato, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14631-14631
Open Access | Times Cited: 48
The molecular pharmacology of glucagon agonists in diabetes and obesity
Aaron Novikoff, Timo D. Müller
Peptides (2023) Vol. 165, pp. 171003-171003
Open Access | Times Cited: 40
Dual GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes
André Scheen
Annales d Endocrinologie (2023) Vol. 84, Iss. 2, pp. 316-321
Closed Access | Times Cited: 33
Sarcopenia and Diabetes: A Detrimental Liaison of Advancing Age
Giuseppe Lisco, Olga Disoteo, Anna De Tullio, et al.
Nutrients (2023) Vol. 16, Iss. 1, pp. 63-63
Open Access | Times Cited: 31
Structure, function and drug discovery of GPCR signaling
Lin Cheng, Fan Xia, Ziyan Li, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 29
Brain uptake pharmacokinetics of albiglutide, dulaglutide, tirzepatide, and DA5-CH in the search for new treatments of Alzheimer’s and Parkinson’s diseases
Elizabeth M. Rhea, Alice Babin, P. C. Thomas, et al.
Tissue Barriers (2023) Vol. 12, Iss. 4
Open Access | Times Cited: 27
The importance of glucose‐dependent insulinotropic polypeptide receptor activation for the effects of tirzepatide
Lærke S. Gasbjerg, Mette M. Rosenkilde, Juris J. Meier, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 11, pp. 3079-3092
Closed Access | Times Cited: 24
Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes
Robert M. Gutgesell, Rubén Nogueiras, Matthias H. Tschöp, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 5, pp. 1069-1084
Open Access | Times Cited: 13
Cryo-electron microscopy for GPCR research and drug discovery in endocrinology and metabolism
Jia Duan, Xinheng He, Shujie Li, et al.
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 6, pp. 349-365
Closed Access | Times Cited: 12
Molecular features of the ligand-free GLP-1R, GCGR and GIPR in complex with Gs proteins
Zhaotong Cong, Fenghui Zhao, Yang Li, et al.
Cell Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 11
New Insights into the Structure and Function of Class B1 GPCRs
Brian P. Cary, Xin Zhang, Jianjun Cao, et al.
Endocrine Reviews (2022) Vol. 44, Iss. 3, pp. 492-517
Open Access | Times Cited: 35
Tirzepatide and prevention of chronic kidney disease
Catalina Bosch, Sol Carriazo, María José Soler, et al.
Clinical Kidney Journal (2022) Vol. 16, Iss. 5, pp. 797-808
Open Access | Times Cited: 33
360-Degree Perspectives on Obesity
Magdalena Cuciureanu, Cătălin-Cezar Caratașu, Levon Gabrielian, et al.
Medicina (2023) Vol. 59, Iss. 6, pp. 1119-1119
Open Access | Times Cited: 20
Structural insights into the triple agonism at GLP-1R, GIPR and GCGR manifested by retatrutide
Wenzhuo Li, Qingtong Zhou, Zhaotong Cong, et al.
Cell Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Biased agonism and polymorphic variation at the GLP-1 receptor: Implications for the development of personalised therapeutics
Liliane El Eid, Christopher A. Reynolds, Alejandra Tomás, et al.
Pharmacological Research (2022) Vol. 184, pp. 106411-106411
Open Access | Times Cited: 27
Structural insights into ligand recognition and subtype selectivity of the human melanocortin-3 and melanocortin-5 receptors
Wenbo Feng, Qingtong Zhou, Xianyue Chen, et al.
Cell Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 14
A Revolution in the Treatment of Obesity
Reynold Spector
The American Journal of Medicine (2024) Vol. 137, Iss. 10, pp. 925-928
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top